Green Tea and the Heart: A Decades-Long Relationship
One of the most consistent findings in nutritional epidemiology involves green tea and cardiovascular outcomes. The landmark Ohsaki cohort study, tracking over 40,000 Japanese adults, found that people who drank five or more cups of green tea daily had significantly lower rates of cardiovascular disease mortality. Matcha, as whole-leaf concentrated green tea, provides the same beneficial compounds in fewer servings.
LDL Cholesterol and Arterial Health
The primary cardiovascular mechanism linked to green tea catechins involves LDL cholesterol — specifically, the oxidation of LDL particles that initiates arterial plaque formation. EGCG inhibits this oxidation process, and meta-analyses of randomized controlled trials have found that green tea catechin supplementation reduces total LDL cholesterol by an average of 3–5 mg/dL. Matcha also supports endothelial function: studies measuring flow-mediated dilation found improvements following regular green tea consumption, suggesting catechins help maintain the vessel responsiveness critical for blood pressure regulation.
Anti-Inflammatory Effects and Context
Chronic low-grade inflammation drives cardiovascular disease progression. Matcha's polyphenols consistently reduce circulating inflammatory markers like C-reactive protein (CRP) in human studies. Matcha isn't a cardiovascular intervention — it's a food. The evidence supports that regular ceremonial matcha, as part of a health-conscious lifestyle, contributes to meaningful cardiovascular benefits accumulated over years of consistent use.